Product image of Illina (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Illina

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Illina (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol / Levonorgestrel, the active ingredients in Illina, are a combined oral contraceptive presented as a tablet for oral use. They work together to inhibit ovulation and create cervical mucus changes, providing reliable pregnancy prevention for women of reproductive age.

GNH India supplies Illina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The product complies with European Union standards and is available for prescription use in multiple countries.

Manufacturer / TM Owner

Hexal Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Illina, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

  • Contraception: Prevents pregnancy in women of reproductive age.
  • Menstrual cycle regulation: Helps achieve regular menstrual bleeding patterns.
  • Acne management: May improve hormonal acne in some women.

How It Works

  • Ethinylestradiol and levonorgestrel act synergistically by binding to estrogen and progesterone receptors, respectively. The estrogen component stabilizes the endometrial lining, while the progestin suppresses the luteinizing hormone surge, inhibiting ovulation. Together they thicken cervical mucus and alter the endometrium, creating an environment unsuitable for fertilization and implantation.

Side Effects

Common side effects are generally mild and transient.

Common Side Effects

  • Nausea: mild stomach upset, often resolves with continued use.
  • Breast tenderness: temporary swelling or discomfort.
  • Headache: mild to moderate intensity.
  • Spotting or breakthrough bleeding: irregular bleeding during the first months.
  • Weight gain: slight increase in fluid retention.
  • Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in leg veins.
  • Pulmonary embolism: clot migration to lung vessels.
  • Stroke: interruption of cerebral blood flow.
  • Myocardial infarction: heart attack risk, especially in smokers.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Liver tumor: rare hepatic adenoma development.

Precautions & Warnings

Before prescribing Illina, clinicians should assess individual risk factors and provide counseling.

  • Assess thromboembolic risk: evaluate personal and family history of clotting disorders.
  • Avoid smoking: especially in women over 35 years of age.
  • Monitor blood pressure: hypertension may increase cardiovascular risk.
  • Review liver function: hepatic impairment can alter drug metabolism.
  • Check concurrent medications: potential interactions may affect efficacy.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Illina may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness.
  • Rifampin and other rifamycins: decrease hormone levels, risking breakthrough pregnancy.
  • St. John's wort: herbal inducer that can lower plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Certain antibiotics (e.g., tetracycline, metronidazole): may slightly diminish efficacy.
  • Antifungal agents (e.g., ketoconazole, itraconazole): can increase hormone levels, raising side‑effect risk.
  • Selective serotonin reuptake inhibitors (SSRIs): may enhance mood‑related side effects.

Frequently Asked Questions

Illina is a combined oral contraceptive tablet containing ethinylestradiol and levonorgestrel. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and the endometrium.

Ethinylestradiol provides estrogenic activity that stabilizes the endometrial lining, while levonorgestrel, a progestin, suppresses the luteinizing hormone surge, preventing ovulation. Together they thicken cervical mucus and create an environment that is hostile to sperm and implantation.

The dosing regimen for Illina is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle outlined by the prescriber, and patients should follow that individualized schedule.

Illina is intended for use only when pregnancy is not present. If pregnancy occurs, the medication should be discontinued. Safety during breastfeeding has not been fully established; women should discuss risks and benefits with their healthcare provider.

To order Illina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Illina contains the same active components—ethinylestradiol and levonorgestrel—as many other combined oral contraceptives. Differences may lie in tablet formulation, dosage strength, and packaging, but the overall efficacy and mechanism of action are comparable across products in this class.

Illina tablets should be stored at ambient temperature, below 25 °C, in their original packaging. They must be kept away from moisture, direct sunlight, and excessive heat to maintain potency throughout their shelf life.

Illina is taken orally, usually once daily at the same time each day, as directed by the prescriber. The tablet is swallowed whole with water and should not be split, crushed, or chewed.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction, particularly in smokers or women with pre‑existing risk factors. Rarely, severe allergic reactions or liver tumors may occur, requiring immediate medical attention.

Illina is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided by smokers over 35 years of age and individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT